ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

67,122Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 117

$4.67M Total Retail Price of All Prescriptions

Rank: 1 out of 117

1,287 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
94% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 1,287 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

35% of this provider’s 1,287 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

2% of this provider’s 46,865 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$70 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

52 is the average number of prescriptions (including refills) per patient, compared to an average of 26.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
HYDROCODONE-ACETAMINOPHEN 2,453 1,664 S3 1 3
POTASSIUM CHLORIDE 2,398 1,919 10 2 11
FUROSEMIDE 2,107 1,769 3 4
LEVOTHYROXINE SODIUM 1,952 1,544 4 1
SIMVASTATIN 1,934 1,422 5 2
AMLODIPINE BESYLATE 1,874 1,429 6 5
QUETIAPINE FUMARATE 1,563 1,042 10 7 20
LISINOPRIL 1,252 802 8 6
DONEPEZIL HCL 1,245 1,119 9 10
LANTUS 1,158 814 10 10 25
OMEPRAZOLE 1,125 809 11 9
NAMENDA 1,121 999 12 7
GABAPENTIN 984 570 13 12
DIVALPROEX SODIUM 960 548 14 37
SERTRALINE HCL 960 762 14 16
METOPROLOL TARTRATE 948 663 16 8
ESCITALOPRAM OXALATE 898 650 17 29
METFORMIN HCL 898 524 17 15
RANITIDINE HCL 857 591 19 43
WARFARIN SODIUM 787 667 20 13
OLANZAPINE 769 498 21 67
CITALOPRAM HBR 737 564 22 18
MIRTAZAPINE 736 632 23 14
RISPERIDONE 646 413 24 35
CYMBALTA 627 386 25 27
TRAZODONE HCL 616 312 26 23
ZOLPIDEM TARTRATE 590 278 27 24
TAMSULOSIN HCL 556 458 28 31
NOVOLIN R 553 339 29 40
METOPROLOL SUCCINATE 531 423 30 17
SEROQUEL 528 362 10 31 57
CARVEDILOL 517 374 32 22
BUMETANIDE 516 371 33 127
PANTOPRAZOLE SODIUM 463 338 34 39
NOVOLOG 463 389 34 60
RAMIPRIL 438 326 36 63
ABILIFY 431 236 37 75
ISOSORBIDE MONONITRATE ER 427 341 38 48
CLONIDINE HCL 423 283 39 52
TRAMADOL HCL 414 280 40 19
MELOXICAM 409 302 41 70
FAMOTIDINE 404 320 42 49
EXELON 391 348 43 34
CLOPIDOGREL 384 314 44 30
BENZTROPINE MESYLATE 372 154 R 45 97
POLYETHYLENE GLYCOL 3350 367 267 46 61
HYDROCHLOROTHIAZIDE 346 186 47 28
NEXIUM 339 219 48 36
ALLOPURINOL 338 278 49 66
DIVALPROEX SODIUM ER 334 166 50 83
GLIMEPIRIDE 320 193 51 87
ZIPRASIDONE HCL 309 165 52 174
ALENDRONATE SODIUM 295 223 53 26
PREDNISONE 289 234 54 47
PHENYTOIN SODIUM EXTENDED 284 198 55 96
DIGOXIN 282 251 56 45
FENTANYL 282 173 S2 56 103
LYRICA 275 179 58 73
IPRATROPIUM-ALBUTEROL 273 217 59 59
HALOPERIDOL 272 170 60 154
LEXAPRO 268 189 61 86
CARBIDOPA-LEVODOPA 267 227 62 53
NUEDEXTA 267 177 10 62 152
BACLOFEN 261 100 64 74
PROMETHAZINE HCL 259 165 R 65 77
METOCLOPRAMIDE HCL 258 119 66 91
FLUOXETINE HCL 257 134 67 95
SPIRIVA 252 179 68 80
ATENOLOL 241 180 69 42
SPIRONOLACTONE 231 156 70 69
PLAVIX 230 180 71 41
PAROXETINE HCL 229 135 72 82
ALBUTEROL SULFATE 226 141 73 68
LEVETIRACETAM 225 101 74 46
TOPIRAMATE 224 67 75 160
CARBAMAZEPINE 223 72 76 128
CELEBREX 220 156 77 134
CIPROFLOXACIN HCL 219 160 78 56
ATORVASTATIN CALCIUM 216 173 79 21
FLUTICASONE PROPIONATE 210 134 80 44
DIOVAN 208 187 81 38
LEVOFLOXACIN 203 133 82 55
AMIODARONE HCL 201 178 83 98
NYSTATIN 190 144 84 81
ADVAIR DISKUS 183 147 85 71
FINASTERIDE 182 148 86 111
VENLAFAXINE HCL ER 180 88 87 78
PRAVASTATIN SODIUM 179 145 88 33
SINGULAIR 171 108 89 99
FENOFIBRATE 171 128 89 118
BUSPIRONE HCL 170 113 91 105
IPRATROPIUM BROMIDE 166 87 92 93
GEODON 164 91 93 236
ZYPREXA 163 106 94 200
LITHIUM CARBONATE 160 83 95 238
GLIPIZIDE 159 99 96 51
VALPROIC ACID 158 86 97 147
HUMALOG 158 95 97 137
CYCLOBENZAPRINE HCL 153 89 R 99 110
DILTIAZEM 24HR CD 152 149 100 133
SULFAMETHOXAZOLE-TRIMETHOPRIM 151 95 101 79
ROPINIROLE HCL 150 91 102 89
AZITHROMYCIN 148 104 103 64
LOSARTAN POTASSIUM 145 134 104 32
CEPHALEXIN 143 109 105 123
KLOR-CON M20 143 114 105 54
NITROGLYCERIN PATCH 142 128 107 168
CRESTOR 140 103 108 58
TRAVATAN Z 139 135 109 104
CEFTRIAXONE 137 95 110 129
TERAZOSIN HCL 137 127 110 178
CLOZAPINE 136 67 112 245
AMITRIPTYLINE HCL 135 80 R 113 184
NITROFURANTOIN MONO-MACRO 132 89 114 100
HYDRALAZINE HCL 131 92 115 50
OXYBUTYNIN CHLORIDE 129 68 116 121
MEGESTROL ACETATE 129 98 R 116 135
ENALAPRIL MALEATE 128 108 118 72
LISINOPRIL-HYDROCHLOROTHIAZIDE 127 81 119 90
TRICOR 124 75 120 119
LIDOCAINE HCL 122 81 121 125
TRIAMCINOLONE ACETONIDE 120 87 122 145
MONTELUKAST SODIUM 120 82 122 158
HYDROXYZINE HCL 113 93 R 124 175
HUMULIN R 111 66 125 109
LATANOPROST 110 109 126 84
JANUVIA 109 103 127 88
GENERLAC 109 66 127 141
KLOR-CON M10 108 83 129 76
DOXAZOSIN MESYLATE 108 59 129 124
AGGRENOX 108 87 129 153
DILTIAZEM HCL 106 75 132 177
CILOSTAZOL 106 104 132 139
DICYCLOMINE HCL 106 85 132 264
GLYBURIDE 105 77 R 135 108
PREMARIN 103 49 R 136 169
COMBIVENT 102 70 137 232
PRIMIDONE 93 57 138 179
OXCARBAZEPINE 92 16 139 180
LACTULOSE 89 58 140 65
LIDODERM 89 30 140 62
ENOXAPARIN SODIUM 88 58 142 212
ZETIA 87 42 143 130
CLONIDINE 86 53 144 136
AMLODIPINE BESYLATE-BENAZEPRIL 85 75 145 114
BUPROPION XL 85 59 145 271
TRIAMTERENE-HCTZ 84 58 147 94
OXYBUTYNIN CHLORIDE ER 83 56 148 85
AVODART 83 83 148 187
INSULIN SYRINGE 82 51 150 138
NITROSTAT 80 70 151 182
LAMOTRIGINE 80 26 151 156
RISPERDAL CONSTA 79 38 153 224
MUPIROCIN 79 49 153 113
METFORMIN HCL ER 78 59 155 199
NOVOLIN 70-30 77 39 156 165
GLIPIZIDE ER 77 41 156 143
CEFUROXIME 76 58 158 144
DIOVAN HCT 76 74 158 115
PROPRANOLOL HCL 75 32 160 192
SYMBICORT 75 58 160 205
CARISOPRODOL 72 14 R 162 208
LEVEMIR 72 40 162 107
BUPROPION HCL 70 57 164 233
ACTOS 70 51 164 161
LUMIGAN 69 41 166 251
NYSTOP 66 44 167 173
ACETAZOLAMIDE 66 43 167 249
THEOPHYLLINE ANHYDROUS 63 37 169 283
ONDANSETRON HCL 62 38 170 202
KLOR-CON 10 62 50 170 229
PROAIR HFA 62 29 170 151
NITROFURANTOIN 61 19 173 148
VERAPAMIL ER 61 50 173 213
TIZANIDINE HCL 60 22 175 234
NIFEDIPINE ER 60 44 175 116
IBUPROFEN 60 28 175 158
INVEGA 60 12 175 289
PHENYTOIN 59 28 179 175
SUCRALFATE 58 43 180 162
DETROL LA 58 30 180 146
SOTALOL 57 49 182 292
SEROQUEL XR 56 37 183 189
LIPITOR 56 23 183 131
VENLAFAXINE HCL 55 38 185 140
TORSEMIDE 54 35 186 206
CHLORHEXIDINE GLUCONATE 52 26 187 254
NOVOLOG MIX 70-30 51 22 188 302
ESTRADIOL 51 30 R 188 302
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 3, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.